Cargando…
Artesunate suppresses Th17 response via inhibiting IRF4-mediated glycolysis and ameliorates Sjog̈ren’s syndrome
Autores principales: | Xiao, Fan, Rui, Ke, Han, Man, Zou, Liyun, Huang, Enyu, Tian, Jie, Zhang, Lijun, Jiang, Quan, Wu, Yuzhang, Lu, Liwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420730/ https://www.ncbi.nlm.nih.gov/pubmed/36031634 http://dx.doi.org/10.1038/s41392-022-01103-x |
Ejemplares similares
-
IL‐17 drives salivary gland dysfunction via inhibiting TRPC1‐mediated calcium movement in Sjögren’s syndrome
por: Xiao, Fan, et al.
Publicado: (2021) -
The Multiple Roles of B Cells in the Pathogenesis of Sjögren’s Syndrome
por: Du, Wenhan, et al.
Publicado: (2021) -
IRF9 and XAF1 as Diagnostic Markers of Primary Sjogren Syndrome
por: Xiao, Lu, et al.
Publicado: (2022) -
Olfactory Ecto-mesenchymal Stem Cell-derived Exosomes Ameliorate Murine Sjögren’s Syndrome via Suppressing Tfh Cell Response
por: Rui, Ke, et al.
Publicado: (2022) -
Artesunate influences Th17/Treg lymphocyte balance by modulating Treg apoptosis and Th17 proliferation in a murine model of rheumatoid arthritis
por: Liu, Jia, et al.
Publicado: (2017)